Carregando...
Can denosumab be a substitute, competitor, or complement to bisphosphonates?
Osteoblasts, originating from mesenchymal cells, make the receptor activator of the nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in order to control differentiation of activated osteoclasts, originating from hematopoietic stem cells. When the RANKL binds to the RANK of the pre-ost...
Na minha lista:
| Publicado no: | Korean J Pain |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Pain Society
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5392661/ https://ncbi.nlm.nih.gov/pubmed/28416991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3344/kjp.2017.30.2.86 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|